SIME DIAGNOSTICS
shaping a future without acute respiratory disease
“There is an urgent need for fast and accurate data tools
that can directly inform clinical intervention”
Professor Henrik Verder, World Renowned Pediatrician and SIME Co-founder
“A simple bedside test that could improve the lives
of millions of premature babies”
“SIME selected as one of 100 global companies with the most potential
to influence, or change, or create, new global markets”
We diagnose disease IN THE INTENSIVE CARE UNIT HOURs before SYMPTOMS occur
Our compact point-of-care device and AI diagnostic platform* help clinicians to deliver life-saving results in just minutes. Developed for use in a critical care setting, our device is reagent-free and easy to use. Fast, precise and decisive – this is the future of ICU diagnostics.
RAPID PREDICTION OF LUNG DISEASE AT BIRTH GIVES BABIES IN THE NICU A FIGHTING CHANCE
Our first products are designed for the neonatal intensive care ward, where we are breaking the cycle of respiratory disease in pre-term babies. Using AI technology to predict Respiratory Distress Syndrome (RDS) and Chronic Lung Disease (CLD/BPD) at birth, our technology helps to ensure early, targeted and preventative treatment – when it matters most.
LEARN MORE about our nicu products
Point-of-care Device & disposable
PROPRIETARY AI & ALGORITHMS
SOFTWARE, CLOUD & UNIQUE DATABASE
PRODUCT PIPELINE: RESPIRATORY INTENSIVE CARE*
Powered by unique data, our Intensive Care Clinical AI Platform delivers life saving solutions in the NICU & ICU.
NEONATAL Respiratory Distress Syndrome (RDS)
NEONATAL CHRONIC LUNG DISEASE (CLD/BPD)
ADULT ACUTE RESPIRATORY DISTRESS (ARDS/COVID-19)
15 million babies
Globally, 15 million babies are born too soon and 1 million children die each year due to complications caused by preterm birth. Some are born with under-developed lungs which, if left undiagnosed, can lead to Respiratory Distress Syndrome and Chronic Lung Disease. Find out how we are helping clinicians treat early and prevent these life-threatening diseases.
*For investigational use only
